Latest News

Sanofi improves outlook on strength of bestseller Dupixent
Sanofi improves outlook on strength of bestseller Dupixent

French drug maker Sanofi has revised its outlook for 2022 upwards after reporting strong sales growth in the third quarter on Friday. While Sanofi faced struggles in producing a jab against Covid, its Dupixent drug, which treats conditions including asthma and eczema, has been a huge success.

Air France-KLM Q3 turnover above pre-Covid levels
Air France-KLM Q3 turnover above pre-Covid levels

European airline group Air France-KLM said Friday that its third quarter revenues had exceeded its pre-pandemic turnover in 2019, fuelled by strong post-Covid demand for travel. The result exceeded the equivalent figure for 2019, the last pre-pandemic year, by more than 500 million euros.

NatWest shares slump as bank earnings spook market
NatWest shares slump as bank earnings spook market

Shares in British bank NatWest tumbled nine percent Friday following an earnings update that added to concerns that borrowers would be unable to repay loans owing to soaring interest rates. Shares in NatWest were down nine percent at 225 pence following the update, a much bigger loss than any other company trading on London's benchmark FTSE 100 index.